Covestro develops new medical polycarbonate
24 Jan 2024
NEWS RELEASE: New Covestro medical polycarbonate pushes the boundaries of heat resistance
• Combines biocompatibility, heat-resistance, transparency and durability
• Boosts productivity in silicone overmolding applications
• Can contribute to customer sustainability goals
Overmolding polycarbonate with liquid silicone rubber (LSR) is commonly used to produce respiratory masks and other medical devices requiring molded-in seals. Now, Covestro, a leading producer of advanced polymers and high-performance plastics has developed Apec® 2045—a copolycarbonate with the highest heat resistance—enabling molders and medical OEMs to significantly slash production time and cost, without sacrificing quality, performance or appearance.
“We work closely with our healthcare customers, and recognized that we could offer a polycarbonate made for highest curing temperatures in silicone overmolding, helping them more than double production volumes in the same amount of time due to shorter cycle times,” said Pierre Moulinie, Global Healthcare Technology Lead, Covestro LLC.
“Our experts provide support every step of the way,” he continued, “helping our customers calculate possible savings when switching to this new high-heat Apec® copolycarbonate grade—for example, simulating material performance in specific applications and calculating cost benefits with our LSR calculator tool.”
In addition to offering high heat resistance and high productivity, Apec® 2045 copolycarbonate offers many other important benefits for this market. These include:
Durability: Tough engineering plastic with the highest heat resistance in the medical polycarbonate portfolio
Transparency: Produces transparent parts with high optical clarity
Biocompatible: Biocompatibility testing according to ISO 10993-1 and USP Class VI for contact of 30 days or less
Sterilizable: Supports sterilization methods most prevalent in the healthcare industry, including irradiation, autoclave and hot air
Processability: Consistent and efficient processing
Furthermore, using this new material may contribute to customer sustainability goals, as it can enable circular business models by supporting close- and open-loop recycling, as well as the possibility of attributed bio-circular content.
Attendees at MD&M West, February 6-8 in Anaheim, California, can visit the Covestro booth (#2221) to learn how the company’s materials push boundaries in healthcare applications.
Polycarbonates from Covestro are found in some of modern technology’s most essential medical devices and play a major role in developing next-generation, life-saving technology. Used in applications where strength, clarity and toughness are necessary, polycarbonates from Covestro exemplify the innovation, safety and biocompatibility that healthcare and life sciences designers and manufacturers across the world have come to know and trust. To learn more about how your company can use Covestro’s material expertise to enhance your medical and healthcare manufacturing, visit our Solution Center.
About Covestro:
Covestro is one of the world’s leading manufacturers of high-quality polymer materials and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. Covestro supplies customers around the world in key industries such as mobility, building and living, as well as the electrical and electronics sector. In addition, polymers from Covestro are also used in sectors such as sports and leisure, cosmetics and health, as well as in the chemical industry itself.
The company is committed to becoming fully circular and is striving to become climate neutral by 2035 (scope 1 and 2). Covestro generated sales of EUR 18 billion in fiscal 2022. At the end of 2022, the company had 50 production sites worldwide and employed approximately 18,000 people (calculated as full-time equivalents).
Find more information at .
Read our Corporate Blog.
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.